These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 12406945)

  • 1. Prevalence of infection with carcinogenic human papillomavirus among older women.
    Sellors JW; Karwalajtys TL; Kaczorowski JA; Mahony JB; Lytwyn A; Chong S; Sparrow J; Lorincz A;
    CMAJ; 2002 Oct; 167(8):871-3. PubMed ID: 12406945
    [No Abstract]   [Full Text] [Related]  

  • 2. Screening for cervical cancer: should we test for infection with high-risk HPV?
    Meijer CJ; Snijders PJ; van den Brule AJ
    CMAJ; 2000 Sep; 163(5):535-8. PubMed ID: 11006764
    [No Abstract]   [Full Text] [Related]  

  • 3. Prevalence and predictors of human papillomavirus infection in women in Ontario, Canada. Survey of HPV in Ontario Women (SHOW) Group.
    Sellors JW; Mahony JB; Kaczorowski J; Lytwyn A; Bangura H; Chong S; Lorincz A; Dalby DM; Janjusevic V; Keller JL
    CMAJ; 2000 Sep; 163(5):503-8. PubMed ID: 11006760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in strategies for human papillomavirus genital disease.
    Apgar BS
    Am Fam Physician; 1997 Apr; 55(5):1545-6, 1548. PubMed ID: 9105185
    [No Abstract]   [Full Text] [Related]  

  • 5. Human papillomavirus DNA testing in community screening for diseases of the cervix uteri.
    Chan SY
    Clin Sci (Lond); 1996 Sep; 91(3):250-2. PubMed ID: 8869401
    [No Abstract]   [Full Text] [Related]  

  • 6. Correspondence Re: M. Schiffman and A. Schatzkin, test reliability is critically important to molecular epidemiology: an example from studies of human papillomavirus infection and cervical neoplasia. Cancer Res. (suppl.), 54: 1944s-1947s, 1994.
    Bosch FX; de Sanjosé S; Muñoz N
    Cancer Res; 1994 Dec; 54(23):6288-9. PubMed ID: 7954479
    [No Abstract]   [Full Text] [Related]  

  • 7. [Use of the Digene Hybrid Capture System for identification of the human papillomavirus (HPV-Human Papillomavirus) in women with cervical dysplasia].
    Kwaśniewska A; Semczuk M; Sikorski M; Kraczkowski J
    Przegl Lek; 1997; 54(12):848-50. PubMed ID: 9591452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human papillomavirus infection in the female population of Antwerp, Belgium: prevalence in healthy women, women with premalignant lesions and cervical cancer.
    Baay MF; Tjalma WA; Weyler J; Goovaerts G; Buytaert P; Van Marck EA; Lardon F; Vermorken JB
    Eur J Gynaecol Oncol; 2001; 22(3):204-8. PubMed ID: 11501772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human papillomavirus and other risk factors for cervical cancer.
    Bosch FX; Muñoz N; de Sanjosé S
    Biomed Pharmacother; 1997; 51(6-7):268-75. PubMed ID: 9309247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human Papillomavirus DNA detection for cervical cancer screening.
    Press RD
    Mol Diagn; 2000 Sep; 5(3):245-7. PubMed ID: 11186127
    [No Abstract]   [Full Text] [Related]  

  • 11. HPV primary screening for cervical cancer: more pain than protection.
    Davey DD; Armenti CA
    Diagn Cytopathol; 2000 Jun; 22(6):333-5. PubMed ID: 10820524
    [No Abstract]   [Full Text] [Related]  

  • 12. [Epidemiology and natural history of genital infection by human papillomavirus].
    Riethmuller D; Schaal JP; Mougin C
    Gynecol Obstet Fertil; 2002 Feb; 30(2):139-46. PubMed ID: 11910884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determinants of human papillomavirus types 16 and 18 infections in the lower female genital tract in an Italian population.
    Venuti A; Badaracco G; Sedati A; Carbini R; Marcante ML
    Eur J Gynaecol Oncol; 1994; 15(3):205-10. PubMed ID: 7957325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Human papillomavirus genotype distribution in cervical infections among woman in La Plata, Argentina].
    Abba MC; Gomez MA; Golijow CD
    Rev Argent Microbiol; 2003; 35(2):74-9. PubMed ID: 12920987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human papillomavirus type distribution among women with cervical pathology - a study over 4 years at Jimma Hospital, southwest Ethiopia.
    Bekele A; Baay M; Mekonnen Z; Suleman S; Chatterjee S
    Trop Med Int Health; 2010 Aug; 15(8):890-3. PubMed ID: 20545913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low prevalence of high-risk HPV in older women not attending organized cytological screening: a pilot study.
    Wikström I; Stenvall H; Wilander E
    Acta Derm Venereol; 2007; 87(6):554-5. PubMed ID: 17989903
    [No Abstract]   [Full Text] [Related]  

  • 17. Evaluating the role of HPV testing for women with equivocal Papanicolaou test findings.
    Cox JT
    JAMA; 1999 May; 281(17):1645-7. PubMed ID: 10235161
    [No Abstract]   [Full Text] [Related]  

  • 18. Dysplasia and HPV infection initially detected by DNA analysis in cytomorphologically normal cervical smears.
    Saito J; Sumiyoshi M; Nakatani H; Ikeda M; Hoshiai H; Noda K
    Int J Gynaecol Obstet; 1995 Oct; 51(1):43-8. PubMed ID: 8582517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of and risks for cervical human papillomavirus infection and squamous intraepithelial lesions in adolescent girls: impact of infection with human immunodeficiency virus.
    Moscicki AB; Ellenberg JH; Vermund SH; Holland CA; Darragh T; Crowley-Nowick PA; Levin L; Wilson CM
    Arch Pediatr Adolesc Med; 2000 Feb; 154(2):127-34. PubMed ID: 10665598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular epidemiology of HPV infection using a clinical array methodology in 2952 women in Greece.
    Tsiodras S; Hatzakis A; Spathis A; Margari N; Meristoudis C; Chranioti A; Kyrgiou M; Panayiotides J; Kassanos D; Petrikkos G; Nasioutziki M; Loufopoulos A; Paraskevaidis E; Karakitsos P
    Clin Microbiol Infect; 2011 Aug; 17(8):1185-8. PubMed ID: 21595788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.